Blum K - Search Results

1

Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Blum K, Chen TJ, Bailey J, Bowirrat A, Femino J, Chen AL, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Oscar-Berman M. Blum K, et al. Mol Neurobiol. 2011 Dec;44(3):250-68. doi: 10.1007/s12035-011-8206-0. Epub 2011 Sep 24. Mol Neurobiol. 2011. PMID: 21948099 Free PMC article.

2

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Blum K, et al. Pharmacogenetics. 1995 Jun;5(3):121-41. doi: 10.1097/00008571-199506000-00001. Pharmacogenetics. 1995. PMID: 7550364 Review.

3

The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theorem.

Blum K, Wood RC, Braverman ER, Chen TJ, Sheridan PJ. Blum K, et al. Funct Neurol. 1995 Jan-Feb;10(1):37-44. Funct Neurol. 1995. PMID: 7649500 Review.

4

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE. Blum K, et al. J R Soc Med. 1996 Jul;89(7):396-400. doi: 10.1177/014107689608900711. J R Soc Med. 1996. PMID: 8774539 Free PMC article. Review.

5

Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill population.

Braverman ER, Blum K. Braverman ER, et al. Among authors: blum k. Clin Electroencephalogr. 1996;27(4 Suppl):5-27. doi: 10.1177/1550059496027s0402. Clin Electroencephalogr. 1996. PMID: 8902324

6

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE. Blum K, et al. J Psychoactive Drugs. 2000 Nov;32 Suppl:i-iv, 1-112. doi: 10.1080/02791072.2000.10736099. J Psychoactive Drugs. 2000. PMID: 11280926 Review.

7

P300 (latency) event-related potential: an accurate predictor of memory impairment.

Braverman ER, Blum K. Braverman ER, et al. Among authors: blum k. Clin Electroencephalogr. 2003 Jul;34(3):124-39. doi: 10.1177/155005940303400306. Clin Electroencephalogr. 2003. PMID: 14521274 Clinical Trial.

8

Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.

Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER. Chen TJ, et al. Among authors: blum k. Med Hypotheses. 2004;63(3):538-48. doi: 10.1016/j.mehy.2004.02.051. Med Hypotheses. 2004. PMID: 15288384 Clinical Trial.

9

From brain science to brain based medicine.

Braverman ER, Blum K, Stanford M. Braverman ER, et al. Among authors: blum k. Med Hypotheses. 2004;63(5):919-20. doi: 10.1016/j.mehy.2004.05.012. Med Hypotheses. 2004. PMID: 15488673 No abstract available.

10

Innate properties of H-Wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies by affecting tissue circulation: a hypothesis.

Blum K, Chen TJ, Ross BD. Blum K, et al. Med Hypotheses. 2005;64(5):1066-7. doi: 10.1016/j.mehy.2004.11.033. Med Hypotheses. 2005. PMID: 15780518 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

818 results

Search Page